Janssen Prevails In Patent Battle With Mylan Over Generics
A New Jersey federal judge has ruled that Mylan cannot pursue a generic version of Janssen's schizophrenia drug Invega Trinza, finding that although the patent for Trinza has expired, Mylan's generic...To view the full article, register now.
Already a subscriber? Click here to view full article